Aptus will follow their Cancer Treatment program with AptaBreast: Preclinical Development of an aptamer for cancer treatment, supported by MICINN RETOS-COLABORACIÓN 2019.

AptaBreast project aims to address the preclinical phase (non-regulatory and regulatory) by the aptamer development for breast cancer therapy (Aptus Biotech and FIBio-HRC), as well as to study its potential efficacy in pancreatic cancer treatment (UAM).